| Certification: | ISO, FDA, HACCP |
|---|---|
| Assay Method: | HPLC |
| Application Form: | Paste, Tablet, Capsule |
| Application: | Food, Health Care Products |
| State: | Powder |
| Extract Source: | Eruca Vesicaria |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
Product Name: Eruca Vesicaria Extract
Botanic Name: Eruca Vesicaria
Specification: 4:1 10:1 ,1-5%cariins
Part of used: Leaf
Appearance: Brown fine powder
| PRODUCT SPECIFICATIONS | ||
| Product Name: | Eruca sativa extract | |
| Botanic Name: | Eruca vesicaria | |
| Scientific name(Family/Genus/Species) | Brassicaceae/Eruca/E.vesicaria | |
| Part of plant | Leaf | |
| Solvent extraction | 30% water & 70% ethanol | |
| Country of Origin: | China | |
| Excipent | 10% maltodextrin | |
| ANALYSIS ITEMS | SPECIFICATION | TEST METHOD |
| Appearance | Fine powder | Organoleptic |
| Color | Brown | Visual |
| Odour & Taste | Characteristic | Organoleptic |
| Identification | Identical to R.S. sample | HPTLC |
| Icariins | 4:1 10:1, 1-5%cariins |
HPLC |
| Extract ratio | 5:1 | |
| Solubility | Partly soluble in water | Organoleptic |
| Hydrocarbons PAHs | ≤ 50 ppb -Reg.UE 1933/2015 | GC-MS |
| Benzo(a)pyren | ≤ 10 ppb -Reg.UE 1933/2015 | GC-MS |
| Radioactivity | ≤ 600 Bq/Kg -Reg. CE 1409/2009 | Gamma spectrometry |
| Apparent density | 0.4-0.7g/ml | Eur.Ph. <2.9.34> |
| Sieve Analysis | 100% through 80 mesh | USP39 <786> |
| Loss on drying | ≤ 5.0% | Eur.Ph.9.0 [2.5.12] |
| Total Ash | ≤ 5.0% | Eur.Ph.9.0 [2.4.16] |
| Lead (Pb) | ≤ 3.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Arsenic (As) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Cadmium(Cd) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Mercury(Hg) | ≤ 0.1 mg/kg -Reg.EC629/2008 | Eur.Ph.9.0<2.2.58>ICP-MS |
| Heavy metal | ≤ 10.0 mg/kg | Eur.Ph.9.0<2.4.8> |
| Solvents Residue | Conform Eur.ph. 9.0 <5,4 > and EC European Directive 2009/32 | Eur.Ph.9.0<2.4.24> |
| Pesticides Residues | Conform Regulations(EC) No.396/2005 including annexes and successive updates Reg.2008/839/CE | Gas Chromatography |
| Aerobic bacteria(TAMC) | ≤1000 cfu/g | USP39 <61> |
| Yeast/Moulds(TAMC) | ≤100 cfu/g | USP39 <61> |
| Bile-tol.gram- b./Enterobact.: | ≤100 cfu/g | |
| Escherichia coli: | Absent in 1g | USP39 <62> |
| Salmonella spp: | Absent in 25g | USP39 <62> |
| Staphylococcus aureus: | Absent in 1g | |
| Listeria Monocytogenens | Absent in 25g | |
| Aflatoxins B1 | ≤ 5 ppb -Reg.EC 1881/2006 | USP39 <62> |
| Aflatoxins ∑ B1, B2, G1, G2 | ≤ 10 ppb -Reg.EC 1881/2006 | USP39 <62> |
Eruca Vesicaria Extract Treatment of prostate, breast, cervical, colon, ovarian cancers
Eruca Vesicaria Extract Anti-bacterial and anti-viral
Eruca Vesicaria Extract Preventing neural tube defects in the newborns
Eruca Vesicaria Extract Preventing Human Papilloma Virus (HPV)
Eruca Vesicaria Extract Protecting from skin, lung and oral cavity cancers
Eruca Vesicaria Extract Good for metabolic
Eruca Vesicaria Extract Protecting from scurvy disease, develop resistance against infectious agents (boosts immunity) and Eruca Vesicaria Extract scavenge harmful, pro-inflammatory free radicals from the body
Eruca Vesicaria Extract Limiting neuronal damage in the brain
Eruca Vesicaria Extract Treatment of patients suffering from Alzheimer's disease
COMPANY PROFILE
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}